SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what im...
SmartTRAK takes a look at the trends impacting the Extremities Market in 2024 and beyond. SmartTRAK prov...
From OEM manufacturers getting dressings approved in the US to pressure injury prevention focus - SmartT...
Rich ongoing data updates and comprehensive expert analyses will deliver evolving market trends and cond...
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, Sm...
Medtronic executives discuss how the Company is making waves in interventional pain, minimally invasive ...
Throughout 2023, SmartTRAK led the way in helping you Be The Expert in the MedTech industry. Serving as ...
Forces likely to influence the Total Joints Market in 2024 Final Q423 US Total Joints Market results are...
SmartTRAK talks with Hybrisan CEO Dr. Mortimer to discuss the challenge of biofilms and the Company’s jo...
SmartTRAK joined industry colleagues in London to explore new technologies at an exciting time in wound ...
Login